Frost tolerance of eight olive cultivars

En este trabajo se estudia la relacion entre la resistencia al frio de 8 variedades de olivo observada en campo y la medida en laboratorio, a partir de la temperatura de congelacion letal. Se observo una correlacion entre el porcentaje de brotes helado y la temperatura de congelacion letal 50%. Las variedades mas resistentes fueron Cornicabra, Arbequina y Picual. Las mas sensibles fue Empeltre

Relevant optical properties for gingiva-colored resin-based composites

The authors acknowledge funding support from the Spanish Ministry of Science, Innovation and Universities (PGC2018-101904-A-100) and from the i+D+I Government of Andalusia 2020, Spain (P20-00200).Objectives: To evaluate the optical properties of gingiva-colored resin-based composites (GCRBCs). Methods: Five discs (8 mm diameter x 1mm height) of 17 shades of GCRBCs were prepared. Diffuse reflectance was measured against white and black backgrounds using a calibrated spectroradiometer, CIE D65 illuminant and the CIE 45⁰/0⁰ geometry. Relative translucency parameter was calculated using ΔE00 (RTP00). Translucency differences were evaluated using published data of 50:50% translucency perceptibility (TPT00) and acceptability (TAT00) thresholds. Scattering (S) and absorption (K) coefficients and transmittance (T%) were calculated using Kubelka–Munk’s equations. Data were statistically analyzed using Kruskal–Wallis, Mann–Whitney tests, and VAF coefficient. Results: The RTP00 values of the 17 evaluated shades ranged from 8.69 to 21.34. There were perceptible translucency differences (TPT00=0.62) between different shades of the same brand and between composites designated with the same shade of different brands. Spectral distributions of S, K and T were wavelength- dependent. Although the spectral behavior of the S and K coefficients and T% were similar for all the gingival composites evaluated, the values of these parameters presented statistically significant differences between shades, which would justify the differences found in the relative translucency parameter. Conclusions: The optical properties S, K and T% of GCRBCs were significantly different, resulting in perceptible translucency differences between the same shade of different commercial brands and between different shades of the same brand. Clinical significance: Translucency differences of gingiva-colored composites may significantly influence their masking ability affecting the clinician’s choice of restorative material.Spanish Ministry of Science, Innovation and Universities (PGC2018-101904-A-100)i+D+I Government of Andalusia 2020, Spain (P20-00200

Acontecimientos vitales y hospitalización psiquiátrica en pacientes maniacos.

Se investigó la incidencia de AV en los seis meses previos al ingreso psiquiátrico y de AV ocurridos durante la infancia en un grupo de 27 pacientes ingresados por un episodio maníaco en un Hospital Psiquiátrico y se comparó con 24 pacientes traumatológicos ingresados en un Hospital General por patología aguda. El grupo de pacientes maniacos presentó más del doble de AV independientes que el grupo control, sin que se encontrasen diferencias significativas en cuanto a la incidencia de AV precoces. Se estudió también el tipo de A V yla relación entre la presencia de éstos y el número de ingresos psiquiátrico

Acontecimientos vitales y hospitalización psiquiátrica en pacientes maniacos.

Se investigó la incidencia de AV en los seis meses previos al ingreso psiquiátrico y de AV ocurridos durante la infancia en un grupo de 27 pacientes ingresados por un episodio maníaco en un Hospital Psiquiátrico y se comparó con 24 pacientes traumatológicos ingresados en un Hospital General por patología aguda. El grupo de pacientes maniacos presentó más del doble de AV independientes que el grupo control, sin que se encontrasen diferencias significativas en cuanto a la incidencia de AV precoces. Se estudió también el tipo de A V yla relación entre la presencia de éstos y el número de ingresos psiquiátrico

A meta-analysis and a functional study support the influence of mtDNA variant m.16519C on the risk of rapid progression of knee osteoarthritis

[Abstract] Objectives: To identify mitochondrial DNA (mtDNA) genetic variants associated with the risk of rapid progression of knee osteoarthritis (OA) and to characterise their functional significance using a cellular model of transmitochondrial cybrids. Methods: Three prospective cohorts contributed participants. The osteoarthritis initiative (OAI) included 1095 subjects, the Cohort Hip and Cohort Knee included 373 and 326 came from the PROspective Cohort of Osteoarthritis from A Coruña. mtDNA variants were screened in an initial subset of 450 subjects from the OAI by in-depth sequencing of mtDNA. A meta-analysis of the three cohorts was performed. A model of cybrids was constructed to study the functional consequences of harbouring the risk mtDNA variant by assessing: mtDNA copy number, mitochondrial biosynthesis, mitochondrial fission and fusion, mitochondrial reactive oxygen species (ROS), oxidative stress, autophagy and a whole transcriptome analysis by RNA-sequencing. Results: mtDNA variant m.16519C is over-represented in rapid progressors (combined OR 1.546; 95% CI 1.163 to 2.054; p=0.0027). Cybrids with this variant show increased mtDNA copy number and decreased mitochondrial biosynthesis; they produce higher amounts of mitochondrial ROS, are less resistant to oxidative stress, show a lower expression of the mitochondrial fission-related gene fission mitochondrial 1 and an impairment of autophagic flux. In addition, its presence modulates the transcriptome of cybrids, especially in terms of inflammation, where interleukin 6 emerges as one of the most differentially expressed genes. Conclusions: The presence of the mtDNA variant m.16519C increases the risk of rapid progression of knee OA. Among the most modulated biological processes associated with this variant, inflammation and negative regulation of cellular process stand out. The design of therapies based on the maintenance of mitochondrial function is recommended

A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?

Introduction: Healthcare-associated (HCA) infections represent a growing public health problem. The aim of this study was to compare community-onset healthcare associated (CO-HCA) bacteremic urinary tract infections (BUTI) and hospital-acquired (HA)-BUTI with special focus on multidrug resistances (MDR) and outcomes. Methods: ITUBRAS-project is a prospective multicenter cohort study of patients with HCA-BUTI. All consecutive hospitalized adult patients with CO-HCA-BUTI or HA-BUTI episode were included in the study. Exclusion criteria were: patients \ 18 years old, non-hospitalized patients, bacteremia from another source or primary bacteremia, non-healthcare related infections and infections caused by unusual pathogens of the urinary tract. Th main outcome variable was 30-day all-cause mortality with day 1 as the first day of positive blood culture. Logistic regression was used to analyze factors associated with clinical cure at hospital discharge and with receiving inappropriate initial antibiotic treatment. Cox regression was used to evaluate 30-day all-cause mortality. Results: Four hundred forty-three episodes were included, 223 CO-HCA-BUTI. Patients with CO-HCA-BUTI were older (p \ 0.001) and had more underlying diseases (p = 0.029) than those with HA-BUTI. The severity of the acute illness (Pitt score) was also higher in CO-HCABUTI (p = 0.026). Overall, a very high rate of MDR profiles (271/443, 61.2%) was observed, with no statistical differences between groups. In multivariable analysis, inadequate empirical treatment was associated with MDR profile (aOR 3.35; 95% CI 1.77?6.35), Pseudomonas aeruginosa (aOR 2.86; 95% CI 1.27?6.44) and Charlson index (aOR 1.11; 95% CI 1.01?1.23). Mortality was not associated with the site of acquisition of the infection or the presence of MDR profile. However, in the logistic regression analyses patients with CO-HCA-BUTI (aOR 0.61; 95% CI 0.40?0.93) were less likely to present clinical cure. Conclusion: The rate of MDR infections was worryingly high in our study. No differences in MDR rates were found between CO-HCA-BUTI and HA-BUTI, in the probability of receiving inappropriate empirical treatment or in 30-day mortality. However, CO-HCA-BUTIs were associated with worse clinical cure.Funding. This study and the journal’s Rapid Service Fee are sponsored and funded by MSD Spain. The study was also supported by Plan Nacional de I+D+i 2013–2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía, Industria y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0004, RD16/ 0016/0005, RD16/0016/0007, RD16/0016/0010, RD16/0016/0011 and RD16/0016/0015), co-financed by the European Development Regional Fund ‘A way to achieve Europe’ (ERDF), Operative program Intelligent Growth 2014–2020

A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?

Introduction: Healthcare-associated (HCA) infections represent a growing public health problem. The aim of this study was to compare community-onset healthcare associated (CO-HCA) bacteremic urinary tract infections (BUTI) and hospital-acquired (HA)-BUTI with special focus on multidrug resistances (MDR) and outcomes. Methods: ITUBRAS-project is a prospective multicenter cohort study of patients with HCA-BUTI. All consecutive hospitalized adult patients with CO-HCA-BUTI or HA-BUTI episode were included in the study. Exclusion criteria were: patients < 18 years old, non-hospitalized patients, bacteremia from another source or primary bacteremia, non-healthcare-related infections and infections caused by unusual pathogens of the urinary tract. The main outcome variable was 30-day all-cause mortality with day 1 as the first day of positive blood culture. Logistic regression was used to analyze factors associated with clinical cure at hospital discharge and with receiving inappropriate initial antibiotic treatment. Cox regression was used to evaluate 30-day all-cause mortality. Results: Four hundred forty-three episodes were included, 223 CO-HCA-BUTI. Patients with CO-HCA-BUTI were older (p < 0.001) and had more underlying diseases (p = 0.029) than those with HA-BUTI. The severity of the acute illness (Pitt score) was also higher in CO-HCA-BUTI (p = 0.026). Overall, a very high rate of MDR profiles (271/443, 61.2%) was observed, with no statistical differences between groups. In multivariable analysis, inadequate empirical treatment was associated with MDR profile (aOR 3.35; 95% CI 1.77–6.35), Pseudomonas aeruginosa (aOR 2.86; 95% CI 1.27–6.44) and Charlson index (aOR 1.11; 95% CI 1.01–1.23). Mortality was not associated with the site of acquisition of the infection or the presence of MDR profile. However, in the logistic regression analyses patients with CO-HCA-BUTI (aOR 0.61; 95% CI 0.40–0.93) were less likely to present clinical cure. Conclusion: The rate of MDR infections was worryingly high in our study. No differences in MDR rates were found between CO-HCA-BUTI and HA-BUTI, in the probability of receiving inappropriate empirical treatment or in 30-day mortality. However, CO-HCA-BUTIs were associated with worse clinical cure. © 2021, The Author(s)

Guia d'actuacions docents universitàries sobre gènere i prevenció de violència de gènere

Aquesta guia és producte del projecte “Prevenció de les violències de gènere des d’una formació basada en evidències científiques” finançat per l’Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) dins dels d’ajuts per a projectes d'innovació per a la millora de la qualitat docent en matèria de violència de gènere (2021 INDOV 0008)Aquest projecte ha contribuït en l'avenç en l'erradicació de la violència de gènere en l'àmbit universitari, a partir de la formació integral de futures i futurs professionals. Aquest objectiu ha estat assolit a través de la creació i consolidació d'entorns de tolerància zero cap la violència i lliures de la mateixa. De forma transversal i al llarg de tot el desenvolupament del projecte, s'ha emfatitzat el reconeixement d’altres formes de violència de gènere fora del context de les parelles. De manera més concreta, a través de les innovacions educatives basades en evidències científiques, seguint la línia de recerca de socialització preventiva de la violència de gènere, el projecte ha dut a terme tasques de sensibilització envers la problemàtica dins l'àmbit universitari, tot aportant a les aules la reflexió respecte factors d'incidència en la violència de gènere o la construcció de les identitats de gènere, entre d'altres. Per fer-ho s'han dut a terme activitats com la lectura de textos científics sobre gènere i prevenció de la violència de gènere, la creació d'espais pel diàleg i el debat, la col·laboració d'actors socials relacionats amb la realitat de la violència de gènere i la incorporació d'eines tecnològiques per a facilitar la construcció de coneixement relacionat amb la prevenció de la violència de gènere. En aquest sentit, s'han donat a conèixer eines d'utilitat que els hi permeten accedir i participar en la construcció de coneixement sobre la temàtica, com és el cas de la plataforma "Sappho". Tot aquest coneixement ha quedat recollit en un document de recomanacions per la docència universitària compromesa en la lluita contra la violència de gènere

Role of age and comorbidities in mortality of patients with infective endocarditis

[Purpose]: The aim of this study was to analyse the characteristics of patients with IE in three groups of age and to assess the ability of age and the Charlson Comorbidity Index (CCI) to predict mortality. [Methods]: Prospective cohort study of all patients with IE included in the GAMES Spanish database between 2008 and 2015.Patients were stratified into three age groups:<65 years,65 to 80 years,and ≥ 80 years.The area under the receiver-operating characteristic (AUROC) curve was calculated to quantify the diagnostic accuracy of the CCI to predict mortality risk. [Results]: A total of 3120 patients with IE (1327 < 65 years;1291 65-80 years;502 ≥ 80 years) were enrolled.Fever and heart failure were the most common presentations of IE, with no differences among age groups.Patients ≥80 years who underwent surgery were significantly lower compared with other age groups (14.3%,65 years; 20.5%,65-79 years; 31.3%,≥80 years). In-hospital mortality was lower in the <65-year group (20.3%,<65 years;30.1%,65-79 years;34.7%,≥80 years;p < 0.001) as well as 1-year mortality (3.2%, <65 years; 5.5%, 65-80 years;7.6%,≥80 years; p = 0.003).Independent predictors of mortality were age ≥ 80 years (hazard ratio [HR]:2.78;95% confidence interval [CI]:2.32–3.34), CCI ≥ 3 (HR:1.62; 95% CI:1.39–1.88),and non-performed surgery (HR:1.64;95% CI:11.16–1.58).When the three age groups were compared,the AUROC curve for CCI was significantly larger for patients aged <65 years(p < 0.001) for both in-hospital and 1-year mortality. [Conclusion]: There were no differences in the clinical presentation of IE between the groups. Age ≥ 80 years, high comorbidity (measured by CCI),and non-performance of surgery were independent predictors of mortality in patients with IE.CCI could help to identify those patients with IE and surgical indication who present a lower risk of in-hospital and 1-year mortality after surgery, especially in the <65-year group